z-logo
open-access-imgOpen Access
Conventional vs concomitant boost radiotherapy with concurrent cisplatin in advanced head and neck cancer
Author(s) -
SushilDashrath Meshram,
K.M. Kamble,
AshokK Diwan,
VijayK Mohobia
Publication year - 2015
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.154940
Subject(s) - medicine , concomitant , head and neck cancer , radiation therapy , cisplatin , complete response , head and neck , progressive disease , surgery , oncology , chemotherapy
To compare outcome of concomitant boost therapy (CBT) with conventional radiotherapy with cisplatin as a radiosensitizer in advanced head and neck cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom